acebutolol and Osteoporotic Fractures

acebutolol has been researched along with Osteoporotic Fractures in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aparicio, R; Bernabeu-Wittel, M; Melero-Bascones, M; Monte-Secades, R; Montero, A; Murcia-Zaragoza, J; Romero, M; Rosso, C; Ruiz-Cantero, A	1

Trials

1 trial(s) available for acebutolol and Osteoporotic Fractures

Article	Year
Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project. BMC musculoskeletal disorders, 2012, Feb-21, Volume: 13 Topics: Aged; Aged, 80 and over; Anemia; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Hip Fractures; Humans; Male; Maltose; Osteoporotic Fractures; Postoperative Hemorrhage; Research Design; Treatment Outcome	2012

Article

Year

Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project.

BMC musculoskeletal disorders, 2012, Feb-21, Volume: 13

Topics: Aged; Aged, 80 and over; Anemia; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Hip Fractures; Humans; Male; Maltose; Osteoporotic Fractures; Postoperative Hemorrhage; Research Design; Treatment Outcome

2012